Neurodesarrollo en pacientes con retinopatía del prematuro tratados con bevacizumab intravítreo. Serie de casos | Zendy

Sarah Melania Martínez-García | Zendy; Sergio E. Hernández-Da Mota | Zendy; Araceli Rubio-Rangel | Zendy; Ignacio Rojas-Flores | Zendy; Mayra Edith Vieyra-López | Zendy; María Ana Martinez-Castellanos | Zendy; María Teresa Zavala-Martínez | Zendy; Anel GómezGarcía | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neurodesarrollo en pacientes con retinopatía del prematuro tratados con bevacizumab intravítreo. Serie de casos

Author(s) -

Sarah Melania Martínez-García,

Sergio E. Hernández-Da Mota,

Araceli Rubio-Rangel,

Ignacio Rojas-Flores,

Mayra Edith Vieyra-López,

María Ana Martinez-Castellanos,

María Teresa Zavala-Martínez,

Anel GómezGarcía

Publication year - 2017

Publication title -

cirugía y cirujanos

Language(s) - Spanish

Resource type - Journals

SCImago Journal Rank - 0.139

H-Index - 16

eISSN - 2444-054X

pISSN - 0009-7411

DOI - 10.1016/j.circir.2016.10.031

Subject(s) - retinopathy of prematurity , medicine , bevacizumab , bayley scales of infant development , pediatrics , gross motor skill , retinal , ophthalmology , gestational age , motor skill , cognition , surgery , pregnancy , psychomotor learning , chemotherapy , genetics , biology , psychiatry

Retinopathy of prematurity (ROP) is an eye disease caused by an alteration in retinal vasculogenesis that may lead to partial or complete vision loss with a harmful impact in terms of neurodevelopment. The purpose of the present study was to determine the neurodevelopment in patients with type i retinopathy of prematurity treated with intravitreal bevacizumab.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research